Skip to content
Abierto
Menu

Presolicitation

OLINK EXPLORE HT SERVICES

75N98026Q00721

National Institutes of Health, National Institutes of Health Olao. Testing Laboratories and Services.

View on SAM.govMarkdown

Response deadline

July 9, 2026 at 9:00 AM EDT

Closed 69 days ago. Posted June 30, 2026. Scheduled to archive July 10, 2026.

Description

As published on SAM.gov.

Background Information: Myelodysplastic Syndromes are heterogeneous stem cell malignancies characterized by chronic inflammation, peripheral cytopenias, and bone marrow dysplasia. LRBGE preliminary data from targeted proteomic arrays has identified substantial changes in the proteome, including secreted proteins in bone marrow plasma from these patients, that may contribute to disease progression.

The program has received Bench to Bedside funding to further interrogate these proteomic changes and identify disease biology and potential therapeutic vulnerabilities. The Olink Explore HT platform is required because it provides high-throughput, multiplexed protein detection using low-volume primary specimens. Olink is the proprietary manufacturer of the Olink Explore HT platform and associated plates.

Although third-party service contractors may theoretically offer related sample-processing support, they would not provide the same Olink Explore HT analysis workflow and may be more expensive while not delivering the same analysis, comparability, or direct platform support required for this project

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. June 30, 2026

    Presolicitation

    Due July 9, 2026 at 9:00 AM EDT. SAM.gov, notice 96183d6dc7b34c49b28afed857635cdf

Points of contact

Also open from this buyer